✦ LIBER ✦

Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer

✍ Scribed by F. Labrie; A. Dupont; M. Giguere; J.P. Borsanyi; A. Belanger; Y. Lacourciere; J. Emond; G. Monfette

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, epirubicin and paclitaxel com

✍ C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Ga 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Combination therapy with flutamide and c

✍ F. Labrie; A. Dupont; M. Giguere; J.P. Borsanyi; Y. Lacourciere; A. Belanger; R. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 1014 KB

Combined modality therapy utilizing a ci

✍ John R. Jacobs; Julie Kish; John F. Ensley; Khurshid Ahmad; Arthur Weaver; John 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Salvage therapy with whole-abdominal irr

✍ William A. Peters III; John C. Blasko; Charles M. Bagley JR; Robert H. Rudolph; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

Phase I study of 3-weekly docetaxel, cap

✍ Sun Jin Sym; Min-Hee Ryu; Hye Jin Kang; Sung Sook Lee; Heung-Moon Chang; Jae Lyu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

896 PUBLICATION Survival advantage and m

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 162 KB